HomeCompareKARBF vs CL

KARBF vs CL: Dividend Comparison 2026

KARBF yields 38.10% · CL yields 2.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 KARBF wins by $167.9K in total portfolio value
10 years
KARBF
KARBF
● Live price
38.10%
Share price
$5.25
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$208.9K
Annual income
$33,891.10
Full KARBF calculator →
CL
CL
● Live price
2.44%
Share price
$85.23
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.0K
Annual income
$5,451.69
Full CL calculator →

Portfolio growth — KARBF vs CL

📍 KARBF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodKARBFCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, KARBF + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
KARBF pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KARBF
Annual income on $10K today (after 15% tax)
$3,238.10/yr
After 10yr DRIP, annual income (after tax)
$28,807.43/yr
CL
Annual income on $10K today (after 15% tax)
$207.44/yr
After 10yr DRIP, annual income (after tax)
$4,633.94/yr
At 15% tax rate, KARBF beats the other by $24,173.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KARBF + CL for your $10,000?

KARBF: 50%CL: 50%
100% CL50/50100% KARBF
Portfolio after 10yr
$124.9K
Annual income
$19,671.40/yr
Blended yield
15.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

KARBF
No analyst data
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+8.5% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KARBF buys
0
CL buys
0
No recent congressional trades found for KARBF or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricKARBFCL
Forward yield38.10%2.44%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$208.9K$41.0K
Annual income after 10y$33,891.10$5,451.69
Total dividends collected$154.9K$18.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: KARBF vs CL ($10,000, DRIP)

YearKARBF PortfolioKARBF Income/yrCL PortfolioCL Income/yrGap
1← crossover$14,510$3,809.52$11,014$313.84+$3.5KKARBF
2$20,691$5,165.83$12,200$415.44+$8.5KKARBF
3$29,024$6,884.70$13,607$553.09+$15.4KKARBF
4$40,081$9,025.64$15,301$741.41+$24.8KKARBF
5$54,536$11,648.73$17,374$1,002.00+$37.2KKARBF
6$73,166$14,812.69$19,958$1,367.44+$53.2KKARBF
7$96,860$18,572.81$23,243$1,887.87+$73.6KKARBF
8$126,620$22,978.99$27,512$2,642.43+$99.1KKARBF
9$163,557$28,073.84$33,197$3,759.22+$130.4KKARBF
10$208,897$33,891.10$40,973$5,451.69+$167.9KKARBF

KARBF vs CL: Complete Analysis 2026

KARBFStock

Karo Pharma AB (publ) develops and markets prescription drugs and over-the-counter products for pharmacies and retail sector in Sweden, Norway, Denmark, Finland, France, Germany, Italy, rest of Europe, the United States, and internationally. It offers skin health products under the Remescar, Locobase, Decubal, and indy beauty brand names; intimate health products under the Pevaryl, Multi Gyn, Asan, and Selexid brand names; and foot health products under the Pevaryl, CCS, Nailner, and wortie brands. The company also provides pain, cough, and cold products under the Paracet, Ibux, Mollipect, and Viruseptin brand names; prescription drugs under the Burinex, Centyl, Kaleorid, and Lithionit brands; and wellness products under the nutravita, Alpha Foods, Flux, Allévo, Dosett, Dax, and Lactocare brands. It sells its products in approximately 90 countries with Europe and the Nordic region markets through direct sales organizations and a network of distributors, as well as online. The company was formerly known as Karo Bio AB (publ) and changed its name to Karo Pharma AB (publ) in March 2016. Karo Pharma AB (publ) was incorporated in 1987 and is headquartered in Stockholm, Sweden.

Full KARBF Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this KARBF vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KARBF vs SCHDKARBF vs JEPIKARBF vs OKARBF vs KOKARBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.